10x GenomicsIncumbent

Owns a high-volume microfluidic bead-encapsulation platform for single-cell sequencing and is actively investing in AI-driven analysis of the resulting data — natural extension to close the loop onto chip control.

Dominates single-cell sequencing instrumentation and is building cloud-based AI analysis tools on top of the data generated by its own platform — infrastructure layer of this collision.

Commercialized droplet microfluidics for single-cell RNA-seq (Chromium platform); already at the exact intersection of gene expression and microfluidic encapsulation.